06:01 PM EDT, 03/28/2024 (MT Newswires) -- John J. Boniface, Chief Scientific Officer, on March 27, 2024, sold 77,136 shares in Sera Prognostics ( SERA ) for $727,853. Following the Form 4 filing with the SEC, Boniface has control over a total of 139,771 shares of the company, with 139,771 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1534969/000153496924000073/xslF345X03/wk-form4_1711662978.xml